Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
The American Journal on Addictions|February 1, 2019
No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up studyZill-E-Huma Latif, Kristin K Solli, Arild Opheim, et al.
JAMA Psychiatry|October 20, 2017
Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority TrialLars Tanum, Kristin Klemmetsby Solli, Zill-E-Huma Latif, et al.
Pakistan Journal of Pharmaceutical Sciences|April 7, 2021
Pharmacological screening and GC-MS analysis of vegetative/reproductive parts of Nigella sativa LArusa Aftab, Zubaida Yousaf, Zill-E-Huma Aftab, et al.
Scientific Reports|September 21, 2023
Impact of silver substitution on the structural, magnetic, optical, and antibacterial properties of cobalt ferriteWaqia Tahir, Talat Zeeshan, Salma Waseem, et al.
JAMA Psychiatry|December 20, 2018
Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up StudyZill-E-Huma Latif, Jurate Šaltyte Benth, Kristin Klemmetsby Solli, et al.
Global Mental Health (Cambridge, England)|December 13, 2017
WHO Parents Skills Training (PST) programme for children with developmental disorders and delays delivered by Family Volunteers in rural Pakistan: study protocol for effectiveness implementation hybrid cluster randomized controlled trialS U Hamdani, P Akhtar, Zill-E-Huma, et al.
The American Journal on Addictions|September 6, 2021
Risk of Relapse Among Opioid-Dependent Patients Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone: A Randomized Clinical TrialArild Opheim, Zhanna Gaulen, Kristin Klemmetsby Solli, et al.
Addiction (Abingdon, England)|May 29, 2018
Effectiveness, safety and feasibility of extended-release naltrexone for opioid dependence: a 9-month follow-up to a 3-month randomized trialKristin Klemmetsby Solli, Zill-E-Huma Latif, Arild Opheim, et al.
European Addiction Research|July 20, 2016
Interest in Extended Release Naltrexone among Opioid UsersKamni Sharma Haase, Nikolaj Kunøe, Arild Opheim, et al.
International Journal of Mental Health Systems|January 13, 2021
Scaling-up school mental health services in low resource public schools of rural Pakistan: the Theory of Change (ToC) approachSyed Usman Hamdani, Zill-E- Huma, Nadia Suleman, et al.
Pageof 8